A new inhaled antibiotic for the treatment of cystic fibrosis called Cayston® is now available for patients through select specialty pharmacies, including the CF Services Pharmacy.
Site Search
Showing 1 - 10 of 17 results
News
|
|
3 min read
News
|
|
2 min read
News
|
|
2 min read
News
|
|
1 min read
News
|
|
2 min read
A key focus of this year's North American Cystic Fibrosis Conference (NACFC) was the progress of the more than 30 potential new therapies moving through the CF Foundation's drug development pipeline.
News
|
|
2 min read
CF Foundation's $1 Million Investment Helped Drug Known as Cayston® Become a Reality
Press Release
|
|
4 min read
Infections are caused by tiny organisms. All germs have one thing in common: When they find a place that is good for them to live, they set up a home for themselves and multiply.
Proposed legislation has the potential to revitalize the global marketplace for novel antibiotics, bringing urgently needed medicines for drug-resistant infections to patients.
Press Release
|
|
2 min read